These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 6980699)

  • 1. Biological markers and breast cancer. A multiparametric study. II. Depressed immune competence.
    Mandeville R; Lamoureux G; Legault-Poisson S; Poisson R
    Cancer; 1982 Oct; 50(7):1280-8. PubMed ID: 6980699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A multiparametric observation of immune competence in breast cancer and its correlation with tumour load and prognosis.
    Das SN; Khanna NN; Khanna S
    Ann Acad Med Singap; 1985 Apr; 14(2):374-81. PubMed ID: 3876055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unspecific cellular immunity before therapy in patients with squamous cell carcinoma of head and neck.
    Bier J; Bitter K; Nicklisch U
    J Maxillofac Surg; 1978 May; 6(2):75-93. PubMed ID: 353210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunobiology of operable breast cancer: an assessment of biologic risk by immunoparameters.
    Wanebo HJ; Rosen PP; Thaler T; Urban JA; Oettgen HF
    Ann Surg; 1976 Sep; 184(3):258-67. PubMed ID: 962394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo and in vitro observation of cellular immune parameters in squamous cell carcinoma of the oral cavity and its correlation with tumor load and prognosis.
    Das SN; Khanna NN; Khanna S
    Cancer Invest; 1986; 4(3):207-16. PubMed ID: 3719410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Intact cellular immune response in patients with locally metastasizing breast carcinoma at the time of diagnosis].
    Ludwig C; Hartmann D; Landmann R; Wesp M; Rosenfelder G; Stucki D; Buser M; Obrecht JP
    Schweiz Med Wochenschr; 1983 Dec; 113(50):1908-11. PubMed ID: 6229873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The immune competence of patients with Crohn's disease (author's transl)].
    Tönnesmann E; Bürkle PA; Schäfer B; Federlin K
    Klin Wochenschr; 1979 Oct; 57(20):1097-107. PubMed ID: 513603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunocompetence, immunosuppression, and human breast cancer. I. An analysis of their relationship by known parameters of cell-mediated immunity in well-defined clinical stages of disease.
    Stein JA; Adler A; Efraim SB; Maor M
    Cancer; 1976 Sep; 38(3):1171-87. PubMed ID: 953963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unaltered immunocompetence in patients with non-disseminated breast cancer at the time of diagnosis.
    Ludwig CU; Hartmann D; Landmann R; Wesp M; Rosenfelder G; Stucki D; Buser M; Obrecht JP
    Cancer; 1985 Apr; 55(8):1673-8. PubMed ID: 3872158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunocompetence, immunosuppression, and human breast cancer. III. Prognostic significance of initial level of immunocompetence in early and advanced disease.
    Adler A; Stein JA; Ben-Efraim S
    Cancer; 1980 Apr; 45(8):2074-83. PubMed ID: 7370953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunocompetence, immunodeficiency and prognosis in cancer.
    Hersh EM; Gutterman JU; Mavligit GM; Mountain CW; McBride CM; Brugess MA; Lurie PM; Zelen M; Takita H; Vincent RG
    Ann N Y Acad Sci; 1976; 276():386-406. PubMed ID: 800324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell-mediated immune competence in patients with prostatic carcinoma.
    Stefani SS; Menon M; Canning JR; Clark SS
    J Urol; 1978 Oct; 120(4):431-4. PubMed ID: 702665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cellular immunity indices in benign breast tumors].
    Baisheva SA; Zhalgasbaeva GT; Kaliev IuSh; Mezinova NN
    Vopr Onkol; 1980; 26(5):15-9. PubMed ID: 7385708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of antiestrogen and progestin on immune functions in breast cancer patients.
    Scambia G; Panici PB; Maccio A; Castelli P; Serri F; Mantovani G; Massidda B; Iacobelli S; Del Giacco S; Mancuso S
    Cancer; 1988 Jun; 61(11):2214-8. PubMed ID: 2966668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Immunocompetence of newborn calves: evaluation of the proliferative response of lymphocytes in vitro to 3 nonspecific mitogens (concanavalin A, phytohemagglutinin, pokeweed mitogen) during the 1st 3 months of life].
    Person JM; Quintin-Colonna F; Barrat F; Le Garrec Y; Pilet C
    Comp Immunol Microbiol Infect Dis; 1983; 6(4):345-56. PubMed ID: 6671377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical studies on cell-mediated immunity in gestational trophoblastic disease: nonspecific cellular immunocompetence in patients with hydatid mole and trophoblastic neoplasia.
    Sasaki T; Fujisaki S
    Microbiol Immunol; 1981; 25(4):387-401. PubMed ID: 6265741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Response of lymphocyte subpopulations to phytohemagglutinin, concanavalin A and pokeweed mitogen in patients with nasopharyngeal carcinoma.
    Hsu MM; Lin BL
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1985 Nov; 18(4):224-31. PubMed ID: 3878769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T-cell deficiency in patients with squamous cell cancer of the head and neck.
    Wanebo HJ; Jun MY; Strong EW; Oettgen H
    Am J Surg; 1975 Oct; 130(4):445-51. PubMed ID: 1101724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delayed cutaneous hypersensitivity, lymphocyte count, and blood tests in patients with breast carcinoma.
    Lee YT
    J Surg Oncol; 1984 Nov; 27(3):135-40. PubMed ID: 6492808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A prospective study of immune responsiveness in human melanoma. I. Assessment of initial pretreatment status with stage of disease.
    Pritchard DJ; Ritts RE; Taylor WF; Miller GC
    Cancer; 1978 Jun; 41(6):2165-73. PubMed ID: 306870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.